Please Wait
Applying Filters...
Menu
Xls

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.businesswire.com/news/home/20250422821349/en/Compass-Pathways-Announces-Dosing-Complete-for-All-Participants-in-Part-A-of-Phase-3-COMP005-Trial-of-COMP360-Psilocybin-for-Treatment-Resistant-Depression

BUSINESSWIRE
22 Apr 2025

https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/bionic-bloom-presents-cannadelic-miami-2025-announces-featured-speake-1012524

ACCESSWIRE
09 Apr 2025

https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/bionic-bloom-presents-cannadelic-miami-2025-1012505

ACCESSWIRE
08 Apr 2025

https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/bionic-bloom-to-host-live-5-meo-dmt-integration-session-1003212

ACCESSWIRE
28 Mar 2025

https://www.businesswire.com/news/home/20250326830443/en/Compass-Pathways-Announces-Completion-of-Recruitment-for-the-Phase-3-COMP005-Trial-of-COMP360-Psilocybin-for-Treatment-Resistant-Depression

BUSINESSWIRE
26 Mar 2025

https://www.prnewswire.com/news-releases/benuvia-operations-awarded-nih-contract-for-gmp-synthesis-of-psilocybin-and-other-bulk-drug-substances-302409450.html

PR NEWSWIRE
25 Mar 2025